Home > Annual Financials > TITAN BIOTECH

TITAN BIOTECH Financial Statement Analysis
[BOM: 524717]

The Revenues of TITAN BIOTECH have decreased by -100.00% YoY .
The Earnings Per Share (EPS) of TITAN BIOTECH has increased by 14.56 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

TITAN BIOTECH Last 5 Annual Financial Results
[BOM: 524717]

ConsolidatedMar2023
Mar2022
Mar2021
Mar2020
Mar2019
Revenues ₹124 Cr₹14,223,723 Cr₹79 Cr₹65 Cr₹57 Cr
Expenses ₹92 Cr₹9,605,092 Cr₹66 Cr₹56 Cr₹50 Cr
Operating Profit (Excl OI) ₹31 Cr₹4,618,631 Cr₹13 Cr₹8.91 Cr₹6.98 Cr
Other Income ₹0.94 Cr₹78,841 Cr₹0.45 Cr₹0.69 Cr₹0.45 Cr
Interest ₹0.87 Cr₹172,744 Cr₹2.35 Cr₹2.34 Cr₹2.39 Cr
Depreciation ₹2.37 Cr₹221,731 Cr₹1.80 Cr₹1.71 Cr₹0.93 Cr
Profit Before Tax ₹29 Cr₹4,270,556 Cr₹10 Cr₹5.54 Cr₹4.10 Cr
Profit After Tax ₹22 Cr₹3,170,529 Cr₹7.84 Cr₹3.91 Cr₹2.67 Cr
Consolidated Net Profit ₹22 Cr₹3,033,521 Cr₹7.07 Cr₹3.52 Cr₹2.54 Cr
Earnings Per Share (Rs)₹30.06₹26.24₹36.71₹8.55₹4.26
PAT Margin (%)14.6017.5522.299.876.03
ROE(%)21.4427.9858.7421.9713.84
ROCE(%)27.4033.7460.8021.4514.88
Total Debt/Equity(x)0.060.090.210.610.74

Key Financials

Market Cap : ₹ 430.9 Cr
Revenue (TTM) : ₹ 161.0 Cr
Net Profit(TTM) : ₹ 23.5 Cr
EPS (TTM) : ₹ 28.3
P/E (TTM) : 18.4

Industry Peers & Returns1W1M1Y
TITAN BIOTECH 5% 0.2% 119.6%
PIDILITE INDUSTRIES -1.1% -3.3% 23.6%
SOLAR INDUSTRIES INDIA 2.5% 3.2% 132%
SRF -2.7% -2% 5%
GUJARAT FLUOROCHEMICALS -1.9% 11.9% 7.4%
DEEPAK NITRITE -1.4% 14.2% 31.3%
TATA CHEMICALS -2.8% 0.4% 15.5%
GODREJ INDUSTRIES NA 10.1% 98.3%
AARTI INDUSTRIES -1.4% 7.7% 32.2%


TITAN BIOTECH Revenues
[BOM: 524717]

Y-o-Y

-100.00 %

5 Yr CAGR

21.14 %

Years Revenues % Change
Mar2023 ₹124 Cr
-100.00
Mar2022 ₹14,223,723 Cr
17,905,338.91
Mar2021 ₹79 Cr
22.39
Mar2020 ₹65 Cr
13.13
Mar2019 ₹57 Cr -


TITAN BIOTECH Operating Profit
[BOM: 524717]

Y-o-Y

-100.00 %

5 Yr CAGR

45.48 %

Years Operating Profit % Change
Mar2023 ₹31 Cr
-100.00
Mar2022 ₹4,618,631 Cr
34,242,419.18
Mar2021 ₹13 Cr
51.47
Mar2020 ₹8.91 Cr
27.58
Mar2019 ₹6.98 Cr -

Operating Margins
Y-o-Y

-22.05 %

5 Yr CAGR

20.09 %

Years Operating Margin% % Change
Mar2023 25.31%
-22.05
Mar2022 32.47%
91.22
Mar2021 16.98%
23.76
Mar2020 13.72%
12.74
Mar2019 12.17% -

TITAN BIOTECH Profit After Tax
[BOM: 524717]

Y-o-Y

-100.00 %

5 Yr CAGR

70.88 %

Years Profit After Tax % Change
Mar2023 ₹22 Cr
-100.00
Mar2022 ₹3,033,521 Cr
42,931,134.93
Mar2021 ₹7.07 Cr
100.62
Mar2020 ₹3.52 Cr
38.50
Mar2019 ₹2.54 Cr -

PAT Margins
Y-o-Y

-16.81 %

5 Yr CAGR

24.74 %

Years PAT Margin(%) % Change
Mar2023 14.6 %
-16.81
Mar2022 17.55 %
-21.27
Mar2021 22.29 %
125.84
Mar2020 9.87 %
63.68
Mar2019 6.03 % -

TITAN BIOTECH Earnings Per Share (EPS)
[BOM: 524717]

Y-o-Y

14.56 %

5 Yr CAGR

62.98 %

Years EPS % Change
Mar2023 ₹30
14.56
Mar2022 ₹26
-28.52
Mar2021 ₹37
329.36
Mar2020 ₹8.55
100.70
Mar2019 ₹4.26 -

TITAN BIOTECH Return on Capital Employed (ROCE)
[BOM: 524717]

Y-o-Y

-18.79 %

5 Yr CAGR

16.49 %

Years ROCE % Change
Mar2023 27.4%
-18.79
Mar2022 33.74%
-44.51
Mar2021 60.8%
183.45
Mar2020 21.45%
44.15
Mar2019 14.88% -

TITAN BIOTECH Share Price vs Sensex

Current Share Price : ₹519.2
Current MarketCap: ₹ 430.9 Cr
Updated EOD on :May 06,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
TITAN BIOTECH

5%

0.2%

119.6%

SENSEX

0.2%

-0.2%

20.9%

TITAN BIOTECH related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about TITAN BIOTECH Financials


How the annual revenues of TITAN BIOTECH have changed ?

The Revenues of TITAN BIOTECH have decreased by -100.00% YoY .

How the Earnings per Share (EPS) of TITAN BIOTECH have changed?

The Earnings Per Share (EPS) of TITAN BIOTECH has increased by 14.56 % YoY .